134 related articles for article (PubMed ID: 8587042)
1. DS-1, a modified Quillaja saponin, enhances ocular and nasal absorption of insulin.
Pillion DJ; Recchia J; Wang P; Marciani DJ; Kensil CR
J Pharm Sci; 1995 Nov; 84(11):1276-9. PubMed ID: 8587042
[TBL] [Abstract][Full Text] [Related]
2. Structure-function relationship among Quillaja saponins serving as excipients for nasal and ocular delivery of insulin.
Pillion DJ; Amsden JA; Kensil CR; Recchia J
J Pharm Sci; 1996 May; 85(5):518-24. PubMed ID: 8742944
[TBL] [Abstract][Full Text] [Related]
3. Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog.
Pillion DJ; Wang P; Yorks J; McCann P; Meezan E
J Ocul Pharmacol Ther; 1995; 11(3):283-95. PubMed ID: 8590261
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of insulin eyedrops.
Pillion DJ; Atchison JA; Stott J; McCracken D; Gargiulo C; Meezan E
J Ocul Pharmacol; 1994; 10(2):461-70. PubMed ID: 8083565
[TBL] [Abstract][Full Text] [Related]
5. Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum.
Sajadi Tabassi SA; Hosseinzadeh H; Ramezani M; Moghimipour E; Mohajeri SA
Curr Drug Deliv; 2006 Oct; 3(4):399-404. PubMed ID: 17076642
[TBL] [Abstract][Full Text] [Related]
6. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
Ahsan F; Arnold JJ; Meezan E; Pillion DJ
Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
[TBL] [Abstract][Full Text] [Related]
7. Nasal delivery of insulin using bioadhesive chitosan gels.
Varshosaz J; Sadrai H; Heidari A
Drug Deliv; 2006; 13(1):31-8. PubMed ID: 16401591
[TBL] [Abstract][Full Text] [Related]
8. Insulin delivery in nosedrops: new formulations containing alkylglycosides.
Pillion DJ; Atchison JA; Gargiulo C; Wang RX; Wang P; Meezan E
Endocrinology; 1994 Dec; 135(6):2386-91. PubMed ID: 7988421
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of intestinal model compound transport by DS-1, a modified Quillaja saponin.
Chao AC; Nguyen JV; Broughall M; Recchia J; Kensil CR; Daddona PE; Fix JA
J Pharm Sci; 1998 Nov; 87(11):1395-9. PubMed ID: 9811496
[TBL] [Abstract][Full Text] [Related]
10. A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.
Recchia J; Lurantos MH; Amsden JA; Storey J; Kensil CR
Pharm Res; 1995 Dec; 12(12):1917-23. PubMed ID: 8786966
[TBL] [Abstract][Full Text] [Related]
11. Delivery of systemic regular insulin via the ocular route in cats.
Morgan RV
J Ocul Pharmacol Ther; 1995; 11(4):565-73. PubMed ID: 8574820
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of nasal absorption of insulin using chitosan nanoparticles.
Fernández-Urrusuno R; Calvo P; Remuñán-López C; Vila-Jato JL; Alonso MJ
Pharm Res; 1999 Oct; 16(10):1576-81. PubMed ID: 10554100
[TBL] [Abstract][Full Text] [Related]
13. Delivery of systemic regular insulin via the ocular route in dogs.
Morgan RV; Huntzicker MA
J Ocul Pharmacol Ther; 1996; 12(4):515-26. PubMed ID: 8951688
[TBL] [Abstract][Full Text] [Related]
14. Effect of formulation on the systemic absorption of insulin from enhancer-free ocular devices.
Lee YC; Yalkowsky SH
Int J Pharm; 1999 Aug; 185(2):199-204. PubMed ID: 10460915
[TBL] [Abstract][Full Text] [Related]
15. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
16. Improvement of systemic absorption of insulin through eyes with absorption enhancers.
Chiou GC; Chuang CY
J Pharm Sci; 1989 Oct; 78(10):815-8. PubMed ID: 2689632
[TBL] [Abstract][Full Text] [Related]
17. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
18. Systemic absorption of insulin delivered topically to the rat eye.
Pillion DJ; Bartlett JD; Meezan E; Yang M; Crain RJ; Grizzle WE
Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3021-7. PubMed ID: 1834605
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of insulin-loaded acrylic hydrogels containing absorption enhancers.
Uchida T; Toida Y; Sakakibara S; Miyanaga Y; Tanaka H; Nishikata M; Tazuya K; Yasuda N; Matsuyama K
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1261-6. PubMed ID: 11605651
[TBL] [Abstract][Full Text] [Related]
20. State of insulin self-association does not affect its absorption from the pulmonary route.
Hussain A; Ahsan F
Eur J Pharm Sci; 2005 Jun; 25(2-3):289-98. PubMed ID: 15911225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
